GSK plc (ETR:GS71)

Germany flag Germany · Delayed Price · Currency is EUR
17.31
+0.11 (0.64%)
Last updated: May 6, 2025
-13.92%
Market Cap 69.45B
Revenue (ttm) 37.69B
Net Income (ttm) 3.77B
Shares Out n/a
EPS (ttm) 0.91
PE Ratio 18.43
Forward PE n/a
Dividend 0.72 (4.18%)
Ex-Dividend Date May 15, 2025
Volume 29,897
Average Volume 976,088
Open 17.18
Previous Close 17.20
Day's Range 17.15 - 17.37
52-Week Range 14.49 - 21.24
Beta 0.30
RSI 45.23
Earnings Date Apr 30, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, infectious, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, inflammation, and other specialty medicine product... [Read more]

Sector Healthcare
Founded 1715
Employees 68,629
Stock Exchange Deutsche Börse Xetra
Ticker Symbol GS71
Full Company Profile

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP Financial Statements

News

There is no news available yet.